MedinCell S.A. (EPA:MEDCL)
France
· Delayed Price · Currency is EUR 16.14
-0.17 (-1.04%)
Jun 6, 2025, 5:35 PM CET
MedinCell Revenue
MedinCell had revenue of 9.44M EUR in the half year ending September 30, 2024, with 22.39% growth. This brings the company's revenue in the last twelve months to 13.20M, down -6.56% year-over-year. In the fiscal year ending March 31, 2024, MedinCell had annual revenue of 11.95M, down -12.52%.
Revenue (ttm)
13.20M
Revenue Growth
-6.56%
P/S Ratio
40.43
Revenue / Employee
100.76K
Employees
134
Market Cap
533.63M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| emeis Société anonyme | 5.64B |
MedinCell News
- 4 months ago - Teva Pharmaceuticals reports completion of phase 3 trial for Olanzapine LAI in Schizophrenia - Seeking Alpha